EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of Human Brucellosis Patients with Post-Treatment Standard Tube Agglutination Test Titers

Aysun Benli iD, Ayşe Nur Ceylan iD

Pathogens · 2025

DOI: 10.3390/pathogens14111186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Aysun Benli und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Clinical Microbiology, Istanbul Faculty of Medicine, University of Istanbul, Istanbul 34093, Turkey. Hauptthemen laut MEDLINE: Brucellosis, Agglutination Tests. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

This study was designed to determine the differences between brucellosis patients whose standard tube agglutination test (SAT) titers decreased or not after successful treatment.

Methods

This retrospective study included patients with a course of antibiotic therapy at least 6 weeks for acute brucellosis or 12 weeks for osteoarticular involvement, and whose post-treatment clinical findings improved.

Results

The mean age of the 276 patients was 45.2 years, and 50.7% were female. The SAT titer decreased in 166 patients (60%). No significant differences were found in terms of demographical and epidemiological characteristics between the groups. Patients with decreased SAT titers exhibited an elevated pre-treatment erythrocyte sedimentation rate (ESR) and the lymphocytosis was more prevalent. In the non-decreased SAT group, liver enzymes such as aspartate aminotransferase (AST) and alanine aminotransferase (ALT) values after treatment were higher. The initial SAT titer of 1/160 and the pre-treatment rates of anaemia and thrombocytopenia were significantly higher in patients whose SAT titers became negative. Among patients whose SAT titers remained positive, the initial SAT titer was more frequently ≥1/320, and the post-treatment AST value was higher.

Conclusions

This study showed that a serological response can be obtained with a high ESR and lymphocytosis prior to treatment. It should be noted that SAT negativity cannot be observed immediately in patients with pre-treatment SAT titers ≥ 1/320. The healthcare providers are advised to consider the complete clinical picture without relying solely on serological results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrucellosisAgglutination TestsHumansFemaleMiddle AgedMaleRetrospective StudiesAdultAnti-Bacterial AgentsAspartate AminotransferasesAlanine TransaminaseAgedBlood SedimentationYoung Adult

Stichwörter der Autor:innen

Brucella spp. brucellosispersistent antibodyserological follow-upstandard tube agglutination test

Substanzen

Anti-Bacterial AgentsAspartate AminotransferasesAlanine Transaminase

Autor:innen und Institutionen

  • Department of Infectious Diseases and Clinical Microbiology, Istanbul Faculty of Medicine, University of Istanbul, Istanbul 34093, Turkey.
  • Department of Medical Microbiology, Basaksehir Çam and Sakura City Hospital, University of Health Science, Istanbul 34480, Turkey.

ORCID-Profile: Aysun Benli, Ayşe Nur Ceylan

Zitieren

APA

Benli, A., & Ceylan, A. N. (2025). Evaluation of Human Brucellosis Patients with Post-Treatment Standard Tube Agglutination Test Titers. Pathogens. https://doi.org/10.3390/pathogens14111186

Vancouver

Benli A, Ceylan AN. Evaluation of Human Brucellosis Patients with Post-Treatment Standard Tube Agglutination Test Titers. Pathogens. 2025. doi:10.3390/pathogens14111186

BibTeX
@article{Benli2025,
  author = {Benli, Aysun and Ceylan, Ayşe Nur},
  title = {Evaluation of Human Brucellosis Patients with Post-Treatment Standard Tube Agglutination Test Titers},
  journal = {Pathogens},
  year = {2025},
  doi = {10.3390/pathogens14111186}
}
Kostenlos starten →